Portal de Periódicos da CAPES

Deregulation of miR-200b, miR-200c and miR-429 indicates its potential relevant role in patients with colorectal cancer liver metastasis

2014; Wiley; Volume: 110; Issue: 4 Linguagem: Inglês

10.1002/jso.23661

1096-9098

Ion Cristóbal, Raúl Rincón, Rebeca Manso, Cristina Caramés, Óscar Aguilera, Juan Madoz‐Gúrpide, Federico Rojo, Jesús García‐Foncillas,

Cancer-related molecular mechanisms research

Journal of Surgical OncologyVolume 110, Issue 4 p. 484-485 Letter to the Editor Deregulation of miR-200b, miR-200c and miR-429 indicates its potential relevant role in patients with colorectal cancer liver metastasis Ion Cristóbal PhD, Corresponding Author Ion Cristóbal PhD Translational Oncology Division, Oncohealth Institute, IIS-Fundacion Jimenez Diaz-UAM, University Hospital "Fundacion Jimenez Diaz", Madrid, Spain Correspondence to: Ion Cristobal, PhD; Oscar Aguilera, PhD; and Jesús García-Foncillas, MD, PhD, Translational Oncology Division, Oncohealth Institute, IIS-Fundacion Jimenez Diaz-UAM, University Hospital "Fundacion Jimenez Diaz", Avda. Reyes Católicos-2, E-28040 Madrid, Spain. Fax: (+34)915443625. E-mail: [email protected] (Cristobal); [email protected] (Aguilera); [email protected] (García-Foncillas)Search for more papers by this authorRaúl Rincón BSc, Raúl Rincón BSc Translational Oncology Division, Oncohealth Institute, IIS-Fundacion Jimenez Diaz-UAM, University Hospital "Fundacion Jimenez Diaz", Madrid, SpainSearch for more papers by this authorRebeca Manso BSc, Rebeca Manso BSc Pathology Department, IIS-Fundacion Jimenez Diaz-UAM, University Hospital "Fundacion Jimenez Diaz", Madrid, SpainSearch for more papers by this authorCristina Caramés, Cristina Caramés Translational Oncology Division, Oncohealth Institute, IIS-Fundacion Jimenez Diaz-UAM, University Hospital "Fundacion Jimenez Diaz", Madrid, SpainSearch for more papers by this authorOscar Aguilera PhD, Corresponding Author Oscar Aguilera PhD Translational Oncology Division, Oncohealth Institute, IIS-Fundacion Jimenez Diaz-UAM, University Hospital "Fundacion Jimenez Diaz", Madrid, Spain Correspondence to: Ion Cristobal, PhD; Oscar Aguilera, PhD; and Jesús García-Foncillas, MD, PhD, Translational Oncology Division, Oncohealth Institute, IIS-Fundacion Jimenez Diaz-UAM, University Hospital "Fundacion Jimenez Diaz", Avda. Reyes Católicos-2, E-28040 Madrid, Spain. Fax: (+34)915443625. E-mail: [email protected] (Cristobal); [email protected] (Aguilera); [email protected] (García-Foncillas)Search for more papers by this authorJuan Madoz-Gurpide PhD, Juan Madoz-Gurpide PhD Pathology Department, IIS-Fundacion Jimenez Diaz-UAM, University Hospital "Fundacion Jimenez Diaz", Madrid, SpainSearch for more papers by this authorFederico Rojo MD, PhD, Federico Rojo MD, PhD Pathology Department, IIS-Fundacion Jimenez Diaz-UAM, University Hospital "Fundacion Jimenez Diaz", Madrid, SpainSearch for more papers by this authorJesús García-Foncillas MD, PhD, Corresponding Author Jesús García-Foncillas MD, PhD Translational Oncology Division, Oncohealth Institute, IIS-Fundacion Jimenez Diaz-UAM, University Hospital "Fundacion Jimenez Diaz", Madrid, Spain Correspondence to: Ion Cristobal, PhD; Oscar Aguilera, PhD; and Jesús García-Foncillas, MD, PhD, Translational Oncology Division, Oncohealth Institute, IIS-Fundacion Jimenez Diaz-UAM, University Hospital "Fundacion Jimenez Diaz", Avda. Reyes Católicos-2, E-28040 Madrid, Spain. Fax: (+34)915443625. E-mail: [email protected] (Cristobal); [email protected] (Aguilera); [email protected] (García-Foncillas)Search for more papers by this author Ion Cristóbal PhD, Corresponding Author Ion Cristóbal PhD Translational Oncology Division, Oncohealth Institute, IIS-Fundacion Jimenez Diaz-UAM, University Hospital "Fundacion Jimenez Diaz", Madrid, Spain Correspondence to: Ion Cristobal, PhD; Oscar Aguilera, PhD; and Jesús García-Foncillas, MD, PhD, Translational Oncology Division, Oncohealth Institute, IIS-Fundacion Jimenez Diaz-UAM, University Hospital "Fundacion Jimenez Diaz", Avda. Reyes Católicos-2, E-28040 Madrid, Spain. Fax: (+34)915443625. E-mail: [email protected] (Cristobal); [email protected] (Aguilera); [email protected] (García-Foncillas)Search for more papers by this authorRaúl Rincón BSc, Raúl Rincón BSc Translational Oncology Division, Oncohealth Institute, IIS-Fundacion Jimenez Diaz-UAM, University Hospital "Fundacion Jimenez Diaz", Madrid, SpainSearch for more papers by this authorRebeca Manso BSc, Rebeca Manso BSc Pathology Department, IIS-Fundacion Jimenez Diaz-UAM, University Hospital "Fundacion Jimenez Diaz", Madrid, SpainSearch for more papers by this authorCristina Caramés, Cristina Caramés Translational Oncology Division, Oncohealth Institute, IIS-Fundacion Jimenez Diaz-UAM, University Hospital "Fundacion Jimenez Diaz", Madrid, SpainSearch for more papers by this authorOscar Aguilera PhD, Corresponding Author Oscar Aguilera PhD Translational Oncology Division, Oncohealth Institute, IIS-Fundacion Jimenez Diaz-UAM, University Hospital "Fundacion Jimenez Diaz", Madrid, Spain Correspondence to: Ion Cristobal, PhD; Oscar Aguilera, PhD; and Jesús García-Foncillas, MD, PhD, Translational Oncology Division, Oncohealth Institute, IIS-Fundacion Jimenez Diaz-UAM, University Hospital "Fundacion Jimenez Diaz", Avda. Reyes Católicos-2, E-28040 Madrid, Spain. Fax: (+34)915443625. E-mail: [email protected] (Cristobal); [email protected] (Aguilera); [email protected] (García-Foncillas)Search for more papers by this authorJuan Madoz-Gurpide PhD, Juan Madoz-Gurpide PhD Pathology Department, IIS-Fundacion Jimenez Diaz-UAM, University Hospital "Fundacion Jimenez Diaz", Madrid, SpainSearch for more papers by this authorFederico Rojo MD, PhD, Federico Rojo MD, PhD Pathology Department, IIS-Fundacion Jimenez Diaz-UAM, University Hospital "Fundacion Jimenez Diaz", Madrid, SpainSearch for more papers by this authorJesús García-Foncillas MD, PhD, Corresponding Author Jesús García-Foncillas MD, PhD Translational Oncology Division, Oncohealth Institute, IIS-Fundacion Jimenez Diaz-UAM, University Hospital "Fundacion Jimenez Diaz", Madrid, Spain Correspondence to: Ion Cristobal, PhD; Oscar Aguilera, PhD; and Jesús García-Foncillas, MD, PhD, Translational Oncology Division, Oncohealth Institute, IIS-Fundacion Jimenez Diaz-UAM, University Hospital "Fundacion Jimenez Diaz", Avda. Reyes Católicos-2, E-28040 Madrid, Spain. Fax: (+34)915443625. E-mail: [email protected] (Cristobal); [email protected] (Aguilera); [email protected] (García-Foncillas)Search for more papers by this author First published: 10 June 2014 https://doi.org/10.1002/jso.23661Citations: 16 Ion Cristóbal, Raúl Rincón, and Rebeca Manso contributed equally to this work. The authors declare that they have no conflict of interest. Read the full textAboutPDF ToolsRequest permissionExport citationAdd to favoritesTrack citation ShareShare Give accessShare full text accessShare full-text accessPlease review our Terms and Conditions of Use and check box below to share full-text version of article.I have read and accept the Wiley Online Library Terms and Conditions of UseShareable LinkUse the link below to share a full-text version of this article with your friends and colleagues. Learn more.Copy URL No abstract is available for this article.Citing Literature Volume110, Issue4September 15, 2014Pages 484-485 RelatedInformation